KalVista Pharmaceuticals, Inc. (KALV) SEC filings
KALV SEC filings moved a median of -0.11% by the close. KALV SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KALV overview →
60 measured KALV SEC filing events.
Where these KALV SEC filings landedvs 55 measured KALV SEC filing reactions
| Middle 50% of KALV SEC filing reactions | -3.37% to +1.91% |
|---|---|
| Median reaction (to close) | -0.11% |
| Measured reactions | 55 |
Point-in-time · zero look-ahead
Half of the 55 KALV SEC filing events with a measured close landed between -3.37% and +1.91%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G KalVista Pharmaceuticals | SEC filing · Form 15-12G | — | — | |
| Form EFFECT KalVista Pharmaceuticals | SEC filing · Form EFFECT | — | — | |
| Form 8-K KalVista Pharmaceuticals For: Jun 11 | SEC filing · Form 8-K | — | — | |
| Form POS AM KalVista Pharmaceuticals | SEC filing · Form POS | — | — | |
| Form S-8 POS KalVista Pharmaceuticals | SEC filing · Form S-8 | — | — | |
| Form 10-Q KalVista Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -0.19% | |
| Form 10-KT/A KalVista Pharmaceuticals For: Dec 31 | SEC filing · Form 10-KT | +0.04% | -0.04% | |
| Form 8-K KalVista Pharmaceuticals For: Apr 29 | SEC filing · Form 8-K | +0.11% | -0.11% | |
| Form 10-KT KalVista Pharmaceuticals For: Dec 31 | SEC filing · Form 10-KT | -1.53% | +11.67% | |
| Form 8-K KalVista Pharmaceuticals For: Mar 25 | SEC filing · Form 8-K | -0.12% | -0.17% | |
| Form S-8 KalVista Pharmaceuticals | SEC filing · Form S-8 | +2.03% | +0.88% | |
| Form 8-K KalVista Pharmaceuticals For: Jan 08 | SEC filing · Form 8-K | -1.45% | -9.68% | |
| Form 10-Q KalVista Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -5.36% | +0.70% | |
| Form 8-K KalVista Pharmaceuticals For: Nov 10 | SEC filing · Form 8-K | -5.36% | +0.70% | |
| Form 8-K KalVista Pharmaceuticals For: Oct 06 | SEC filing · Form 8-K | -2.33% | -8.82% | |
| Form 8-K KalVista Pharmaceuticals For: Oct 01 | SEC filing · Form 8-K | -0.17% | -2.49% | |
| Form 8-K KalVista Pharmaceuticals For: Sep 24 | SEC filing · Form 8-K | +0.00% | -0.25% | |
| Form 10-Q KalVista Pharmaceuticals For: Jul 31 | SEC filing · Form 10-Q | -4.58% | -12.83% | |
| Form 8-K KalVista Pharmaceuticals For: Sep 11 | SEC filing · Form 8-K | -4.58% | -12.83% | |
| Form 8-K KalVista Pharmaceuticals For: Aug 21 | SEC filing · Form 8-K | -0.61% | +2.21% | |
| Form ARS KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form ARS | -0.61% | +2.21% | |
| Form DEF 14A KalVista Pharmaceuticals For: Oct 01 | SEC filing · Form DEF | -0.61% | +2.21% | |
| Form DEFA14A KalVista Pharmaceuticals | SEC filing · Form DEFA14A | -0.61% | +2.21% | |
| Form 10-K KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form 10-K | -2.52% | -2.42% | |
| Form 8-K KalVista Pharmaceuticals For: Jul 10 | SEC filing · Form 8-K | -0.09% | -2.45% | |
| Form 8-K KalVista Pharmaceuticals For: Jul 07 | SEC filing · Form 8-K | -2.36% | +7.57% | |
| Form 8-K KalVista Pharmaceuticals For: May 12 | SEC filing · Form 8-K | +0.37% | -3.48% | |
| Form 8-K KalVista Pharmaceuticals For: Apr 08 | SEC filing · Form 8-K | +0.82% | -10.73% | |
| Form 8-K KalVista Pharmaceuticals For: Mar 13 | SEC filing · Form 8-K | -1.87% | +0.49% | |
| Form 10-Q KalVista Pharmaceuticals For: Jan 31 | SEC filing · Form 10-Q | -0.43% | -0.81% | |
| Form 8-K KalVista Pharmaceuticals For: Mar 12 | SEC filing · Form 8-K | -0.43% | -0.81% | |
| Form S-8 KalVista Pharmaceuticals | SEC filing · Form S-8 | +0.36% | -0.60% | |
| Form 8-K KalVista Pharmaceuticals For: Dec 16 | SEC filing · Form 8-K | -1.86% | +1.02% | |
| Form 10-Q KalVista Pharmaceuticals For: Oct 31 | SEC filing · Form 10-Q | +2.56% | +9.00% | |
| Form 8-K KalVista Pharmaceuticals For: Dec 05 | SEC filing · Form 8-K | +2.56% | +9.00% | |
| Form 8-K KalVista Pharmaceuticals For: Nov 23 | SEC filing · Form 8-K | -0.30% | +1.11% | |
| Form 8-K KalVista Pharmaceuticals For: Nov 04 | SEC filing · Form 8-K | +8.41% | +2.92% | |
| Form 8-K KalVista Pharmaceuticals For: Oct 03 | SEC filing · Form 8-K | +0.00% | +0.09% | |
| Form 8-K KalVista Pharmaceuticals For: Sep 06 | SEC filing · Form 8-K | +1.63% | -3.25% | |
| Form 10-Q KalVista Pharmaceuticals For: Jul 31 | SEC filing · Form 10-Q | -0.53% | -6.09% | |
| Form 8-K KalVista Pharmaceuticals For: Sep 05 | SEC filing · Form 8-K | -0.53% | -6.09% | |
| Form ARS KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form ARS | +0.48% | +1.85% | |
| Form DEF 14A KalVista Pharmaceuticals For: Oct 03 | SEC filing · Form DEF | +0.48% | +1.85% | |
| Form DEFA14A KalVista Pharmaceuticals | SEC filing · Form DEFA14A | +0.48% | +1.85% | |
| Form 8-K KalVista Pharmaceuticals For: Jul 22 | SEC filing · Form 8-K | +0.98% | -5.18% | |
| Form EFFECT KalVista Pharmaceuticals | SEC filing · Form EFFECT | +0.00% | +3.70% | |
| Form 10-K KalVista Pharmaceuticals For: Apr 30 | SEC filing · Form 10-K | -0.71% | +3.25% | |
| Form 8-K KalVista Pharmaceuticals For: Jul 11 | SEC filing · Form 8-K | -0.71% | +3.25% | |
| Form S-3 KalVista Pharmaceuticals | SEC filing · Form S-3 | -0.71% | +3.25% | |
| Form S-8 KalVista Pharmaceuticals | SEC filing · Form S-8 | +0.00% | +1.97% | |
| Form 8-K KalVista Pharmaceuticals For: Apr 18 | SEC filing · Form 8-K | -1.14% | -1.93% | |
| Form 10-Q KalVista Pharmaceuticals For: Jan 31 | SEC filing · Form 10-Q | +0.47% | -2.88% | |
| Form 8-K KalVista Pharmaceuticals For: Mar 11 | SEC filing · Form 8-K | +0.47% | -2.88% | |
| Form 8-K KalVista Pharmaceuticals For: Mar 06 | SEC filing · Form 8-K | +1.23% | +1.56% | |
| Form 8-K KalVista Pharmaceuticals For: Feb 14 | SEC filing · Form 8-K | +0.28% | -5.48% | |
| Form 8-K KalVista Pharmaceuticals For: Feb 14 | SEC filing · Form 8-K | +2.10% | -8.72% | |
| Form 8-K KalVista Pharmaceuticals For: Feb 13 | SEC filing · Form 8-K | -11.83% | -4.50% | |
| Form S-8 KalVista Pharmaceuticals | SEC filing · Form S-8 | +0.46% | +0.79% | |
| Form 10-Q KalVista Pharmaceuticals For: Oct 31 | SEC filing · Form 10-Q | -3.31% | -8.31% | |
| Form 8-K KalVista Pharmaceuticals For: Dec 07 | SEC filing · Form 8-K | -3.31% | -8.31% |
Keep exploring
More KALV: earnings → · analyst actions → · KALV overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EyePoint, Inc. (EYPT) | 439 | -0.25% | 46% |
| Abeona Therapeutics Inc. (ABEO) | 438 | +0.09% | 51% |
| Zymeworks Inc. (ZYME) | 438 | 0.00% | 50% |
| Exact Sciences Corporation (EXAS) | 437 | +0.08% | 56% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.